Caribou Biosciences (CRBU) traded down -4.82 % during a 24 hours period ending at 07:44 PM Central Europe on Monday 26th. One Caribou Biosciences stock can currently be bought for about USD 0.51 on popular exchanges. Current supply of Caribou Biosciences stocks is 107.2 mn. Caribou Biosciences has a current market capitalization of USD 57.1 mn and approximately USD 1.1 mn worth of Caribou Biosciences was traded on exchanges in the last 24 hours. Since last month end, Caribou Biosciences has traded -57.36 % down. Simple moving average of last 200 days is at USD 1.66. The highest price of past 52 weeks was recorded at USD 3.54 on 11/03/2025. 52 weeks low was at USD 0.44 on 10/09/2026.
Here is how related stocks have performed in the past 24 hours:
Catalyst (CLST) traded down -0.31 % and now trades at USD 17.11. Catalyst has a market capitalisation of USD 68.3 mn. Current price/earnings ratio for Catalyst is 31.02.
Medicinova (MNOV) traded down -1.42 % and now trades at USD 1.42. Current market capitalisation for Medicinova is USD 68.4 mn.
Universal Electronics (UEIC) traded up 3.35 % and now trades at USD 5.27. Current market capitalisation for Universal Electronics is USD 67.5 mn.
Rafael (RFL) traded up 2.34 % and now trades at USD 1.26. Current market capitalisation for Rafael is USD 68.1 mn.
Cognition Therapeutics (CGTX) traded up 2.57 % and now trades at USD 0.7. Current market capitalisation for Cognition Therapeutics is USD 68.4 mn.
About Caribou Biosciences
Caribou Biosciences, Inc. is a health care company based in Berkeley, United States, that specializes in providing medical therapies and bio-based products. The company offers therapeutic bioproduction, microbial strains, and agricultural biotechnology products. Caribou Biosciences markets its products globally. You can find more information about their offerings and initiatives on their website, www.cariboubio.com , and they are traded on the Nasdaq stock exchange.